Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-jun Zou

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|February 9, 2011
Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence studyYun Li, Mei-Juan Ding, Jing Ma, et al.
Clinical Therapeutics|January 17, 2021
Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose AdministrationYi-Fan Zhang, Yan-Mei Liu, Chen Yu, et al.
The International Journal of Neuroscience|February 22, 2020
A NAC nomogram to predict the probability of three-month unfavorable outcome in Chinese acute ischemic stroke patients treated with mechanical thrombectomyXiang Li, Yang Zou, Jue Hu, et al.
Basic & Clinical Pharmacology & Toxicology|February 5, 2019
Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approachDan Tang, Bai-Li Song, Miao Yan, et al.
Cardiovascular Therapeutics|September 8, 2012
Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trialShao-Liang Chen, Fei Ye, Jun-Jie Zhang, et al.
Clinical Therapeutics|August 9, 2021
Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male VolunteersZhen-Dong Chen, Qian Chen, Yun-Ting Zhu, et al.
Annals of Translational Medicine|November 26, 2020
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosisMei-Feng Ye, Shan Su, Zhi-Hao Huang, et al.
BMC Medicine|December 20, 2021
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stageShan Su, Mei-Feng Ye, Xiao-Ting Cai, et al.
British Journal of Clinical Pharmacology|October 3, 2020
Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational studyDan Tang, Miao Yan, Bai-Li Song, et al.
Biomed Research International|November 30, 2019
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome SequencingShan Su, Jian-Jun Zou, Yun-Yun Zeng, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Drug Metabolism and Pharmacokinetics|February 9, 2011
Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence studyYun Li, Mei-Juan Ding, Jing Ma, et al.
Clinical Therapeutics|January 17, 2021
Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose AdministrationYi-Fan Zhang, Yan-Mei Liu, Chen Yu, et al.
The International Journal of Neuroscience|February 22, 2020
A NAC nomogram to predict the probability of three-month unfavorable outcome in Chinese acute ischemic stroke patients treated with mechanical thrombectomyXiang Li, Yang Zou, Jue Hu, et al.
Basic & Clinical Pharmacology & Toxicology|February 5, 2019
Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approachDan Tang, Bai-Li Song, Miao Yan, et al.
Cardiovascular Therapeutics|September 8, 2012
Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trialShao-Liang Chen, Fei Ye, Jun-Jie Zhang, et al.
Clinical Therapeutics|August 9, 2021
Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male VolunteersZhen-Dong Chen, Qian Chen, Yun-Ting Zhu, et al.
Annals of Translational Medicine|November 26, 2020
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosisMei-Feng Ye, Shan Su, Zhi-Hao Huang, et al.
BMC Medicine|December 20, 2021
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stageShan Su, Mei-Feng Ye, Xiao-Ting Cai, et al.
British Journal of Clinical Pharmacology|October 3, 2020
Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational studyDan Tang, Miao Yan, Bai-Li Song, et al.
Biomed Research International|November 30, 2019
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome SequencingShan Su, Jian-Jun Zou, Yun-Yun Zeng, et al.
Pageof 5